Mycobacterium bovis disease in a pediatric renal transplant patient.
We describe a pediatric renal transplant patient with Mycobacterium bovis disease who was successfully treated using an antituberculosis regimen that included rifampin. We discuss the history of M. bovis and the diagnosis and management of M. bovis infection in renal transplant patients.
Chen
Sharon F
SF
Department of Pediatrics, University of Minnesota School of Medicine, University of Minnesota Children's Hospital, Fairview, Minneapolis, MN, USA.
Gutierrez
Kathleen
K
D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation / Q000276:immunology*; D009163:Mycobacterium bovis / Q000187:drug effects / Q000302:isolation & purification*; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D012307:Risk Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy*
D000995:Antitubercular Agents